Healthy Skepticism Library item: 3004

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Relman AS.
Who reviews the ads?
N Engl J Med 1979 Nov 1; 301:(18):999

Abstract:

Journals should not and cannot critically review the therapeutic claims and prescribing information in each of the ads that they run. Such a policy would mean that the journals were competing with the Food and Drug Administration which ahs the statutory authority to regulate the advertising of prescription drugs. The New England Journal of Medicine assumes that advertising copy is in compliance with the law and that if it is not the FDA will identify it and deal with it appropriately. Doctors can help this process by complaining to the FDA.

Keywords:
*editorial/United States/journal advertisements/regulation of promotion/attitude toward promotion/Food and Drug Administration/FDA/New England Journal of Medicine/ATTITUDES REGARDING PROMOTION: MEDICAL JOURNALS/PROMOTIONAL TECHNIQUES: JOURNAL ADVERTISEMENTS/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION Advertising* Drug Industry New England Periodicals* Pharmaceutical Preparations* United States United States Food and Drug Administration